Coulter Partners Top hires for VC & PE portfolio companies Q2-2024

PIR International recently partnered with Closed Loop Medicine in appointing Luba Greenwood as Non-Executive Chair

Cushman & Wakefield's Locating Science life sciences report wins top award from the Society of Property Researchers

Pension reform unlocks cash for UK life sciences, London Life Sciences Week and #bioProcessUK are here.

OMass Therapeutics, a biotechnology company identifying medicines against highly validated target ecosystems such as membrane proteins or intracellular complexes, today announces the appointment of Professor Steven Charlton as Chief Scientific Officer (CSO).

Greywolf Therapeutics, a clinical-stage biotech company advancing novel antigen modulation technology that controls T cells to guide the immune system, has appointed Darlene Deptula-Hicks as Chief Financial Officer.